PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 21, 2026Vaccine0 citationsOpen Access

COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024

View Full Paper
NANicholas AmoakoKintampo Health Research CentreSCSandra CohuetHelicon FoundationMAMichael Rockson AdjeiWorld Health Organization - Pakistan

Key Points

  • This research aims to assess the effectiveness of COVID-19 vaccines in preventing hospitalizations due to COVID-19-associated severe acute respiratory infections (SARI) in Ghana.
  • Analyzed hospital data for COVID-19-associated SARI cases from June 2022 to March 2024
  • Focused on laboratory-confirmed cases of SARS-CoV-2
  • Evaluated vaccine effectiveness in reducing hospitalizations
  • COVID-19 vaccines were found to prevent SARI hospitalizations in the initial 6 months of the study period
  • A protective effect was observed, consistent with findings from other regions
  • Effect estimates, however, were noted to be imprecise

Abstract

COVID-19 vaccines may have prevented COVID-19-associated SARI hospitalizations in the first 6 months over the study period in Ghana, and a pattern of protective effective was observed, consistent with report from other settings, although effect estimates were imprecise.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Amoako et al. (2026) studied this question.

synapsesocial.com/papers/69994a7f873532290d01ee73https://doi.org/10.1016/j.vaccine.2026.128310
Ask AI
Helpful
Bookmark
Share
View Full Paper